SCYNEXIS, Inc. (SCYX) vs Zhengye Biotechnology Holding Limited (ZYBT)

SCYNEXIS, Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. SCYNEXIS, Inc. is the larger, with a market value of $45.0M against $40.1M — 1.1× the size. Across the 9 metrics below, Zhengye Biotechnology Holding Limited leads on 6 and SCYNEXIS, Inc. on 3.

Valuation

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 20.14
P/S 2.52 — 2.25
P/B 0.78 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 1.15 n/m 2.56
Earnings yield (47.61%) — (2.99%)
Free cash flow yield (25.67%) 0.00% 0.00%

Profitability

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Gross margin 100.00% — 53.94%
Operating margin (109.90%) — 0.00%
Net margin (49.74%) — 0.00%
Free cash flow margin (64.67%) 0.00% 0.00%
Return on equity (18.38%) 0.00% (0.40%)
Return on assets (15.09%) 0.00% (3.32%)
Return on invested capital (110.72%) 0.00% 0.00%

Growth

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 682.47% — 10.01%
EPS growth (last fiscal year) 61.36% (800.00%) —
Revenue growth, 5-year CAGR 179.40% — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.24 0.05
Current ratio 9.65 1.14 2.31
Net debt to EBITDA 2.54 (0.51) 0.85

Dividend

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 — 0.00

Size

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Market cap 44.98m 40.13m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack